BOERNE, TX, November 12, 2012 – MRL CyberTec Corporation, headquartered in Quezon City, Philippines, with branches in Cebu and Davao, has partnered with Stanbio Laboratory to provide nearly 782 Stanbio HemoPoint® H2 point-of-care hemoglobin testing systems – including analyzers and reagent cuvettes – for the Rizal Medical Center. The medical center is a renowned and well-respected Department of Health facility in the Philippines. The Stanbio hemoglobin testing systems will be distributed throughout the Philippines as part of the Health Facilities Enhancement Program. The HemoPoint® H2 selection by Rizal Medical Center complements other Stanbio successes throughout the Americas – including Mexico where the IMSS OPORTUNIDADES government health initiative focuses on underserved populations.
“It is an honor and a privilege to have our HemoPoint® H2 point-of-care system selected by the Philippines’ Rizal Medical Center,” said Stanbio Laboratory President, William R. Pippin. “Our instruments and cuvettes have been regarded as the premium choice for near-patient hemoglobin testing in U.S. public health clinics, physician offices and hospitals because of their ease-of-use, accuracy and reliability. We are extremely proud to be partnering with our exclusive Philippines distributor, MRL CyberTec Corporation, to help provide this much needed healthcare product and service to its most deserving citizens throughout the country,” Pippin added.
“Stanbio Laboratory has built a solid reputation for producing excellent clinical products,” said Gigi Veslino, MRL CyberTec National Sales Manager. “We have a market here that will be most receptive to the Stanbio offerings,” Veslino said.
MRL CyberTec imports, distributes, and supports equipment, reagents, and supplies for each sector of the medical diagnostic laboratory. The company has more than 80 employees and 30 sales reps serving the laboratory market. The company was established in 1996 and it remains entirely Filipino owned. MRL CyberTec is privileged to be one of the leaders in an industry traditionally dominated by giant multinational companies.
Founded in 1960 and headquartered in Boerne, Texas, Stanbio Laboratory manufactures and markets medical testing and diagnostic devices including clinical chemistry, pregnancy, strep A, serology, urinalysis, and point-of-care hemoglobin tests. Stanbio Laboratory’s Quality System is ISO 13485 registered and its facility operates under USFDA current GMP requirements. Stanbio also offers OEM and private labeling capabilities and distributes products in over 125 countries worldwide. This year the company celebrates its 52nd year in business. To find out more about Stanbio, review its news, or learn more about its products, visit www.stanbio.com.
EKF Diagnostics Holdings plc is a worldwide manufacturer of near-patient care equipment for the measurement of glucose, lactate, hemoglobin, hematocrit and glycated hemoglobin (HbA1c). It offers its products to the professional clinical and research laboratories, doctors’ offices, sports clinics, and athletic testing sites. The company is headquartered in London, the United Kingdom.